Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis
- PMID: 19407228
- PMCID: PMC2701261
- DOI: 10.1161/STROKEAHA.108.546150
Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis
Abstract
Background and purpose: There are limited data on the causes and severity of subsequent stroke in patients presenting initially with TIA or stroke attributed to intracranial arterial stenosis.
Methods: We evaluated the location, type (lacunar vs nonlacunar), cause, and severity of stroke in patients who had an ischemic stroke endpoint in the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) trial.
Results: Of the 569 patients enrolled in the WASID trial, 106 patients (18.6%) had an ischemic stroke during a mean follow-up of 1.8 years. Stroke occurred in the territory of the symptomatic artery in 77 (73%) of 106 patients. Among the 77 strokes in the territory, 70 (91%) were nonlacunar and 34 (44%) were disabling. Stroke out of the territory of the symptomatic artery occurred in 29 (27%) of 106 patients. Among these 29 strokes, 24 (83%) were nonlacunar, 14 (48%) were attributed to previously asymptomatic intracranial stenosis, and 9 (31%) were disabling.
Conclusions: Most subsequent strokes in patients with symptomatic intracranial artery stenosis are in the same territory and nonlacunar, and nearly half of the strokes in the territory are disabling. The most commonly identified cause of stroke out of the territory was a previously asymptomatic intracranial stenosis. Penetrating artery disease was responsible for a low number of strokes.
Figures
References
-
- Barnett HJ, Gunton RW, Eliasziw M, Fleming L, Sharpe B, Gates P, Meldrum H. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA. 2000;283:1429–1436. - PubMed
-
- Stroke prevention in atrial fibrillation study. Final results. Circulation. 1991;84:527–539. - PubMed
-
- Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in atrial fibrillation II study. Lancet. 1994;343:687–691. - PubMed
-
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation iii randomised clinical trial. Lancet. 1996;348:633–638. - PubMed
-
- Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG Warfarin-Aspirin Symptomatic Intracranial Disease Trial I. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. New England Journal of Medicine. 2005;352:1305–1316. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 5M01 RR000750-32/RR/NCRR NIH HHS/United States
- M01 RR165001/RR/NCRR NIH HHS/United States
- M01 RR000750/RR/NCRR NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- 1R01 NS36643/NS/NINDS NIH HHS/United States
- M01 RR00083-42/RR/NCRR NIH HHS/United States
- R01 NS036643/NS/NINDS NIH HHS/United States
- M01 RR00425/RR/NCRR NIH HHS/United States
- M01 RR00039/RR/NCRR NIH HHS/United States
- M01 RR000039/RR/NCRR NIH HHS/United States
- 5M01 RR00080/RR/NCRR NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
- M01 RR000080/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
